Evidence map›Paper›PMID 41449310›Full record

ArticleDiscover oncology2025

Metastatic lung adenocarcinoma causes extensive destruction of the hip and pelvis.

Wenjun Hao, Chaoquan Yang, Wenjun Liu, Zhiling Huang, Haixiao Zhuang, William W Lu, Yan Chen

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenjun Hao *Department of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Chaoquan Yang *Department of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Wenjun LiuDepartment of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhiling HuangDepartment of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Haixiao ZhuangDepartment of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
William W LuDepartment of Orthopaedics and Traumatology, The University of Hong Kong, Hong Kong, China.
Yan ChenDepartment of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. cy003@connect.hku.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer is the most prevalent tumor and frequently present with distant metastases, with the bone being one of the most common affected sites. However, bone metastases leading to complete resorption of the hip joint and pelvis are extremely rare. This case aimed to report an extensive destruction of the hip and pelvis in metastatic lung adenocarcinoma, and conduct a literature review to explore the factors influencing the diagnosis and treatment decisions of bone metastasis. CASE PRESENTATION: A 56-year-old woman presented with progressive pain in her left hip joint and pelvis accompanied by impaired mobility for over one year. X-ray and computed tomography (CT) scan of left hip joint and pelvis showed extensive bone metastasis. A chest X-ray displayed disorganized lung texture in both lungs and multiple bilateral lung nodules of variable sizes. Surgical biopsy of the left iliac bone and histology examination indicated bone metastasis originating from lung adenocarcinoma, which was confirmed using immunohistochemical analysis. Due to multiple extensive metastases throughout the body, the patient was treated conservatively. Targeted therapy with almonertinib mesilate was administered; however, and the patient eventually passed away one week later.

conclusionEarly detection of bone metastasis and identification of the original tumor are crucial, especially when the symptoms are subtle or nonspecific. Delayed diagnosis can lead to extensive skeletal destruction, loss of function, and poor prognosis. A comprehensive diagnostic approach integrating thorough physical examination, advanced imaging modalities, and pathological analysis is essential for timely and accurate diagnosis. An optimal management requires a personalized, multidisciplinary treatment strategy that considers the patient's overall condition, the molecular profile of the primary tumor, and the anatomical complexity of the metastatic site.

Indexed as

Bone metastasisHip destructionLung cancerMultidisciplinary treatmentNeoplasm metastasisPelvic destruction

Identifiers

PMID41449310
PMCPMC12847597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.